Trial0

Clinical trial · NCT06881277

Effectiveness of a Smartphone App (PRIMI) to Promote Healthy Diet and Physical Activity After Pregnancy in Migrant Women

Recruiting

Sponsor: Linkoeping University

We save this real registry record and notify you if its published status changes. Create an account to add profile details that improve future matching.

Summary

The PRIMI trial (Promoting Reproductive health In MIgrant women) is a randomized controlled trial evaluating the effectiveness of a smartphone app designed to promote a healthy diet, physical activity, and health literacy among first-generation migrant women after pregnancy. The study will recruit 200 women within six months after pregnancy and randomize them into an intervention group, receiving access to the PRIMI app for six months, or a wait-list control group. The primary outcomes are diet quality and moderate-to-vigorous physical activity, while secondary outcomes include health literacy, body mass index, self-efficacy, and self-rated health. The intervention is expected to provide accessible and culturally tailored support to improve postpartum health behaviors.

Interventions

  • Mobile phone based intervention · BEHAVIORAL

    The PRIMI intervention is a 6-month smartphone-based digital health program designed to promote a healthy diet and physical activity among migrant women after pregnancy.

Published eligibility criteria

Verbatim from the registry. Only the site can decide how these apply to a specific patient.

Inclusion Criteria:

* First-generation migrant women
* Given birth ≤ 6 months ago
* Age ≥ 18 years
* Able to receive health-related information in Arabic, Somali, English, or Swedish

Exclusion Criteria:

* Swedish-born women
* Age \< 18 years
* Given birth \> 6 months ago

Sites (1)

  • Linköping University, Linköping, Östergötland County · Recruiting

Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors. Registry data refreshed at most hourly; last update posted 2026-08-27.